BVMF/D2OC34 (BVMF/D2OC34)

Brazil Stock Exchange: BVMF/D2OC34 · BRL

R$29.2

+0.00 (0.0%)· Recorded snapshot

Market cap	32.8B
Revenue (ttm)	3.4B
Net income (ttm)	865.4M
EPS (ttm)	R$0.76
P/E (trailing)	38.3x
P/E (forward)	22.3x
Volume	0
Beta	1.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.4B
Net income (ttm): 865.4M
EPS (ttm): R$0.76
P/E (trailing): 38.3x
P/E (forward): 22.3x
Market cap: 32.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E22.3

P25 11.9P50 16.6P75 25.6

Trailing P/E38.3

P25 15.1P50 22.9P75 38.5

ROE17.2

P25 2.7P50 10.8P75 20.1

ROIC65.7

P25 6.3P50 12.1P75 21.3

Benchmarks · 1M

All BVMF/D2OC34 indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	880
Employees change	50
Employees growth	6.02%
Enterprise value	BRL 29.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	March
Founded	2010
Industry	Health Information Services
Is primary listing	No
ISIN number	BRD2OCBDR005
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	BRL 32.8B
Next earnings date	2026-11-05
Price	BRL 29.15
Price currency	BRL
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-26
Symbol	bvmf/D2OC34
Website	https://www.doximity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	38.76x
Average P/E ratio (5Y)	57.23x
Earnings yield	2.61%
EV/Earnings	33.69x
EV/EBIT	27.08x
EV/EBITDA	25.8x
EV/FCF	18.38x
EV/Sales	8.28x
FCF / EV yield	5.44%
FCF yield	4.84%
Forward P/E	22.31x
Graham number	8.54303
Graham upside	-70.69%
Lynch fair value	BRL 19.23
Lynch upside	-34.04%
P/(FCF - SBC) ratio	37.29x
P/(OCF - SBC) ratio	37.28x
P/B ratio	6.91x
P/E ratio	38.32x
P/FCF ratio	20.67x
P/OCF ratio	20.67x
P/S ratio	9.66x
Price / tangible book value	7.94x
Price/EBITDA ratio	30.38x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	30.57%
EBITDA margin	31.79%
Effective tax rate	26.16%
FCF margin	44.69%
Gross margin	88.07%
Operating margin	30.57%
Pretax margin	34.51%
Profit margin	25.48%
Profit per employee	BRL 983,445
Profitable quarters	25
Profitable years	8
Revenue per employee	BRL 3.9M
ROA	10.95%
ROA (5Y)	10.49%
ROCE	21.47%
ROE	17.21%
ROE (5Y)	19.99%
ROIC	65.72%
ROIC (5Y)	107%
SBC / revenue	20.82%
Tax / revenue	9.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-27.94%
EPS growth (Q)	-51.85%
EPS growth (QoQ)	35.31%
EPS growth 3Y	14.56%
EPS growth 5Y	23.7%
EPS growth years	0
FCF growth	4.13%
FCF growth (Q)	-32.49%
FCF growth (QoQ)	-61.72%
FCF growth 3Y	17.05%
FCF growth 5Y	23.38%
Gross profit growth	8.62%
Gross profit growth (Q)	2.16%
Gross profit growth 3Y	14.63%
Gross profit growth 5Y	22.2%
Net income growth	-28.96%
Net income growth (Q)	-54.4%
Net income growth (QoQ)	27.21%
Net income growth 3Y	12.02%
Net income growth 5Y	41.4%
Net income growth years	0
OCF growth	4.16%
OCF growth (Q)	-32.39%
OCF growth (QoQ)	-61.66%
OCF growth 3Y	16.84%
OCF growth 5Y	23.32%
Operating income growth	-16.36%
Operating income growth (Q)	-38.79%
Operating income growth 3Y	14.32%
Operating income growth 5Y	21.21%
Revenue growth	11.18%
Revenue growth (Q)	7.34%
Revenue growth (QoQ)	7.74%
Revenue growth 3Y	14.49%
Revenue growth 5Y	21.94%
Revenue growth quarters	21
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -321,210
Depreciation and amortization	BRL 43.2M
EBIT	BRL 1B
EBITDA	BRL 1.1B
EPS	BRL 0.76
Financing cash flow	BRL -2.2B
Free cash flow	BRL 1.6B
Free cash flow minus SBC	BRL 879.5M
Gross profit	BRL 3B
Income taxes	BRL 306.6M
Investing cash flow	BRL 1.3B
Net cash flow	BRL 706.4M
Net income	BRL 865.4M
Operating cash flow minus SBC	BRL 879.9M
Operating income	BRL 1B
Revenue	BRL 3.4B
Stock-based compensation	BRL 707.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	31.3
Book value per share	BRL 26.39
Debt / EBITDA	0.05
Debt / equity	0.01
Debt / FCF	0.03
Goodwill	BRL 460.3M
Long-term assets	BRL 664.6M
Long-term liabilities	BRL 54.8M
Net cash (debt)	BRL 3.5B
Net cash / market cap	10.71%
Net cash growth	-18.21%
Net debt / EBITDA	-3.25
Net debt / equity	-0.74
Net debt / FCF	-2.21
Piotroski F-Score	5
Property, plant and equipment	BRL 140.8M
Shareholders' equity	BRL 4.7B
Tangible book value	BRL 4.1B
Tangible book value per share	BRL 22.98
Total assets	BRL 5.6B
Total cash	BRL 3.6B
Total debt	BRL 50.1M
Total liabilities	BRL 869.2M
WACC	10.92%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	BRL 5B
Current liabilities	BRL 814.4M
Current ratio	6.08
Net working capital	BRL 403.9M
Quick ratio	5.8
Working capital	BRL 4B
Working capital turnover	4.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.55%
Shareholder yield	2.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 36.94
1D price change	0%
1M price change	27.18%
1M total return	27.18%
1W price change	16.93%
1W total return	16.93%
1Y price change	-52.76%
1Y return CAGR	-52.78%
1Y total return	-52.76%
20-day SMA	BRL 22.99
200-day SMA	BRL 40.93
3M price change	54.81%
3M total return	54.81%
3Y price change	57.57%
3Y return CAGR	16.36%
3Y total return	57.57%
50-day SMA	BRL 20.25
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 63.20
52-week high date	2025-10-27
52-week low	BRL 14.36
52-week low date	2026-05-14
6M price change	48.57%
6M total return	48.57%
All-time high	BRL 82.08
All-time high date	2025-02-10
All-time low	BRL 14.36
All-time low date	2026-05-14
Average true range (ATR)	BRL 1.36
Average volume	897.6
Beta (5Y)	1.22
Change from 52-week high	-53.88%
Change from 52-week low	102.99%
Change from all-time high	-64.49%
Change from all-time low	102.99%
Change from open	0%
Day's gap	0%
High price	BRL 29.15
Low price	BRL 29.15
Monthly RSI	45.3
Open price	BRL 29.15
Previous close	BRL 29.15
Price vs 150-day SMA	-21.09%
Price vs 20-day SMA	26.81%
Price vs 200-day SMA	-28.78%
Price vs 50-day SMA	43.97%
Relative volume	0.06
RSI	73.26
Sharpe ratio	-0.09
Sortino ratio	-0.09
Volume	0
Weekly RSI	47.66
YTD price change	-28.01%
YTD total return	-28.01%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123.6M
Shares change (QoQ)	-1.98%
Shares change (YoY)	-2.55%
Shares held by insiders	28.87%
Shares held by institutions	74.48%
Short ratio	2 days

Deeper analysis on BVMF/D2OC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/D2OC34 report

Is a complete BVMF/D2OC34 research report available?

No complete published report is available for bvmf/D2OC34 (BVMF/D2OC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/D2OC34 (BVMF/D2OC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/D2OC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/D2OC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/D2OC34

Frequently asked questions